Benefits

Imetab benefits

Patients benefit from the early detection of metabolic eye changes that precede structural eye disease opening a new treatment window. David Antonetti “Individuals who have not developed clinically evident retinopathy represent the greatest therapeutic opportunity to preserve vision because they constitute the majority of the patients and respond better to intensive therapy.” Early detection allows appropriate therapy to help preserve patients’ sight and “image the future”.

Eye doctors benefit from the metabolic imaging providing early detection and accurate monitoring of eye disease, allowing eye doctors to “image the future” Imetab metabolic imaging will generate within seconds a subjective retinal metabolic image, an objective assessment of retinal metabolic function and an objective alternative to visual field testing. Sensitive, predictive retinal metabolic imaging will improve the efficiency of clinical practice and clinical trials.